Clinical Trial Update: A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating select drug combinations in adult patients with advanced/metastatic BRAF V600 colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: BRAF V600 Colorectal Cancer | Phase 1 | Status: TERMINATED